SRRK
Price
$45.19
Change
+$1.68 (+3.86%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
4.44B
96 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$6.88
Change
+$0.08 (+1.18%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
262.01M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SRRK vs TARA

Header iconSRRK vs TARA Comparison
Open Charts SRRK vs TARABanner chart's image
Scholar Rock Holding
Price$45.19
Change+$1.68 (+3.86%)
Volume$28.4K
Capitalization4.44B
Protara Therapeutics
Price$6.88
Change+$0.08 (+1.18%)
Volume$5.18K
Capitalization262.01M
SRRK vs TARA Comparison Chart in %
View a ticker or compare two or three
VS
SRRK vs. TARA commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRRK is a Buy and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (SRRK: $43.51 vs. TARA: $6.80)
Brand notoriety: SRRK and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRRK: 79% vs. TARA: 278%
Market capitalization -- SRRK: $4.44B vs. TARA: $262.01M
SRRK [@Biotechnology] is valued at $4.44B. TARA’s [@Biotechnology] market capitalization is $262.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRRK’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • SRRK’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRRK’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • SRRK’s TA Score: 6 bullish, 5 bearish.
  • TARA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than TARA.

Price Growth

SRRK (@Biotechnology) experienced а +0.83% price change this week, while TARA (@Biotechnology) price change was -8.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

SRRK is expected to report earnings on Mar 10, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($4.44B) has a higher market cap than TARA($262M). TARA YTD gains are higher at: 28.788 vs. SRRK (0.671). TARA has higher annual earnings (EBITDA): -57.01M vs. SRRK (-320.22M). SRRK has more cash in the bank: 295M vs. TARA (122M). TARA has less debt than SRRK: TARA (3.95M) vs SRRK (61.5M). SRRK (0) and TARA (0) have equivalent revenues.
SRRKTARASRRK / TARA
Capitalization4.44B262M1,694%
EBITDA-320.22M-57.01M562%
Gain YTD0.67128.7882%
P/E RatioN/AN/A-
Revenue00-
Total Cash295M122M242%
Total Debt61.5M3.95M1,558%
FUNDAMENTALS RATINGS
SRRK vs TARA: Fundamental Ratings
SRRK
TARA
OUTLOOK RATING
1..100
2073
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (19) in the null industry is somewhat better than the same rating for SRRK (62) in the Biotechnology industry. This means that TARA’s stock grew somewhat faster than SRRK’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as SRRK (100) in the Biotechnology industry. This means that TARA’s stock grew similarly to SRRK’s over the last 12 months.

TARA's SMR Rating (97) in the null industry is in the same range as SRRK (99) in the Biotechnology industry. This means that TARA’s stock grew similarly to SRRK’s over the last 12 months.

TARA's Price Growth Rating (35) in the null industry is in the same range as SRRK (38) in the Biotechnology industry. This means that TARA’s stock grew similarly to SRRK’s over the last 12 months.

TARA's P/E Growth Rating (100) in the null industry is in the same range as SRRK (100) in the Biotechnology industry. This means that TARA’s stock grew similarly to SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRRKTARA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
SRRK
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDDCX19.430.28
+1.46%
13D Activist C
IGMIX10.810.06
+0.56%
Voya Global Insights Portfolio I
TEIHX48.070.20
+0.42%
Nuveen Equity Index I
DLCZX12.480.05
+0.40%
Destinations Large Cap Equity Z
RREYX30.590.05
+0.16%
Russell Inv Global Real Estate Secs Y

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with NRIX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+5.92%
NRIX - SRRK
47%
Loosely correlated
+2.94%
IRON - SRRK
43%
Loosely correlated
+2.96%
IMNM - SRRK
43%
Loosely correlated
+13.34%
CGON - SRRK
42%
Loosely correlated
+3.00%
NUVL - SRRK
42%
Loosely correlated
+1.85%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with ITRM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+9.32%
ITRM - TARA
35%
Loosely correlated
+0.77%
CAMP - TARA
34%
Loosely correlated
-1.81%
BRNS - TARA
34%
Loosely correlated
+3.37%
SRRK - TARA
34%
Loosely correlated
+5.92%
TBPH - TARA
32%
Poorly correlated
+2.50%
More